Comprehensive analysis supports SERMs for cutting breast cancer
(HealthDay)—Treatment with selective estrogen receptor modulators (SERMs) is associated with a significant reduction in the incidence of breast cancer, especially for the first five years after treatment, according to research ...
Apr 30, 2013
0
0